357 related articles for article (PubMed ID: 18462791)
1. Circulating and placental endoglin concentrations in pregnancies complicated by intrauterine growth restriction and preeclampsia.
Jeyabalan A; McGonigal S; Gilmour C; Hubel CA; Rajakumar A
Placenta; 2008 Jun; 29(6):555-63. PubMed ID: 18462791
[TBL] [Abstract][Full Text] [Related]
2. Endoglin in pregnancy complicated by fetal intrauterine growth restriction in normotensive and preeclamptic pregnant women: a comparison between preeclamptic patients with appropriate-for-gestational-age weight infants and healthy pregnant women.
Laskowska M; Laskowska K; Oleszczuk J
J Matern Fetal Neonatal Med; 2012 Jun; 25(6):806-11. PubMed ID: 21793708
[TBL] [Abstract][Full Text] [Related]
3. Placental HIF-1 alpha, HIF-2 alpha, membrane and soluble VEGF receptor-1 proteins are not increased in normotensive pregnancies complicated by late-onset intrauterine growth restriction.
Rajakumar A; Jeyabalan A; Markovic N; Ness R; Gilmour C; Conrad KP
Am J Physiol Regul Integr Comp Physiol; 2007 Aug; 293(2):R766-74. PubMed ID: 17507435
[TBL] [Abstract][Full Text] [Related]
4. Proteasomal activity in placentas from women with preeclampsia and intrauterine growth restriction: implications for expression of HIF-alpha proteins.
Rajakumar A; Michael HM; Daftary A; Jeyabalan A; Gilmour C; Conrad KP
Placenta; 2008 Mar; 29(3):290-9. PubMed ID: 18222538
[TBL] [Abstract][Full Text] [Related]
5. Discordant clinical presentations of preeclampsia and intrauterine fetal growth restriction with similar pro- and anti-angiogenic profiles.
Alahakoon TI; Zhang W; Trudinger BJ; Lee VW
J Matern Fetal Neonatal Med; 2014 Dec; 27(18):1854-9. PubMed ID: 24397483
[TBL] [Abstract][Full Text] [Related]
6. Myeloperoxidase in the plasma and placenta of normal pregnant women and women with pregnancies complicated by preeclampsia and intrauterine growth restriction.
Hung TH; Chen SF; Lo LM; Li MJ; Yeh YL; Hsieh TT
Placenta; 2012 Apr; 33(4):294-303. PubMed ID: 22264587
[TBL] [Abstract][Full Text] [Related]
7. Severe intrauterine growth restriction pregnancies have increased placental endoglin levels: hypoxic regulation via transforming growth factor-beta 3.
Yinon Y; Nevo O; Xu J; Many A; Rolfo A; Todros T; Post M; Caniggia I
Am J Pathol; 2008 Jan; 172(1):77-85. PubMed ID: 18156205
[TBL] [Abstract][Full Text] [Related]
8. NFAT5 Is Up-Regulated by Hypoxia: Possible Implications in Preeclampsia and Intrauterine Growth Restriction.
Dobierzewska A; Palominos M; Irarrazabal CE; Sanchez M; Lozano M; Perez-Sepulveda A; Monteiro LJ; Burmeister Y; Figueroa-Diesel H; Rice GE; Illanes SE
Biol Reprod; 2015 Jul; 93(1):14. PubMed ID: 25995271
[TBL] [Abstract][Full Text] [Related]
9. Maternal plasma concentrations of soluble endoglin in pregnancies with intrauterine growth restriction.
Stepan H; Krämer T; Faber R
J Clin Endocrinol Metab; 2007 Jul; 92(7):2831-4. PubMed ID: 17426082
[TBL] [Abstract][Full Text] [Related]
10. Fas and FasL expression in placentas complicated with intrauterine growth retardation with and without preeclampsia.
Rešić Karara J; Zekić Tomas S; Marušić J; Roje D; Kuzmić Prusac I
J Matern Fetal Neonatal Med; 2016; 29(7):1154-9. PubMed ID: 25909501
[TBL] [Abstract][Full Text] [Related]
11. The change in concentrations of angiogenic and anti-angiogenic factors in maternal plasma between the first and second trimesters in risk assessment for the subsequent development of preeclampsia and small-for-gestational age.
Erez O; Romero R; Espinoza J; Fu W; Todem D; Kusanovic JP; Gotsch F; Edwin S; Nien JK; Chaiworapongsa T; Mittal P; Mazaki-Tovi S; Than NG; Gomez R; Hassan SS
J Matern Fetal Neonatal Med; 2008 May; 21(5):279-87. PubMed ID: 18446652
[TBL] [Abstract][Full Text] [Related]
12. Increased expression of N-myc downstream-regulated gene 1 (NDRG1) in placentas from pregnancies complicated by intrauterine growth restriction or preeclampsia.
Choi SJ; Oh SY; Kim JH; Sadovsky Y; Roh CR
Am J Obstet Gynecol; 2007 Jan; 196(1):45.e1-7. PubMed ID: 17240229
[TBL] [Abstract][Full Text] [Related]
13. A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate.
Romero R; Nien JK; Espinoza J; Todem D; Fu W; Chung H; Kusanovic JP; Gotsch F; Erez O; Mazaki-Tovi S; Gomez R; Edwin S; Chaiworapongsa T; Levine RJ; Karumanchi SA
J Matern Fetal Neonatal Med; 2008 Jan; 21(1):9-23. PubMed ID: 18175241
[TBL] [Abstract][Full Text] [Related]
14. Altered expression of plasminogen activator inhibitor type 1 in placentas from pregnant women with preeclampsia and/or intrauterine fetal growth retardation.
Estellés A; Gilabert J; Keeton M; Eguchi Y; Aznar J; Grancha S; Espña F; Loskutoff DJ; Schleef RR
Blood; 1994 Jul; 84(1):143-50. PubMed ID: 8018914
[TBL] [Abstract][Full Text] [Related]
15. [Mast cells, histamine and development of the placental vascular network in pregnancies complicated by preeclampsia and intrauterine growth retardation].
Szewczyk G; Szewczyk A; Pyzlak M; Klimkiewicz J; Smiertka W; Szukiewicz D
Ginekol Pol; 2005 Sep; 76(9):727-34. PubMed ID: 16417085
[TBL] [Abstract][Full Text] [Related]
16. Expression of 52-kDa FK506-binding protein (FKBP52) in human placenta complicated by preeclampsia and intrauterine growth restriction.
Acar N; Ustunel I
Anal Quant Cytopathol Histpathol; 2015 Apr; 37(2):87-95. PubMed ID: 26065228
[TBL] [Abstract][Full Text] [Related]
17. Metformin as a prevention and treatment for preeclampsia: effects on soluble fms-like tyrosine kinase 1 and soluble endoglin secretion and endothelial dysfunction.
Brownfoot FC; Hastie R; Hannan NJ; Cannon P; Tuohey L; Parry LJ; Senadheera S; Illanes SE; Kaitu'u-Lino TJ; Tong S
Am J Obstet Gynecol; 2016 Mar; 214(3):356.e1-356.e15. PubMed ID: 26721779
[TBL] [Abstract][Full Text] [Related]
18. Placental productions and expressions of soluble endoglin, soluble fms-like tyrosine kinase receptor-1, and placental growth factor in normal and preeclamptic pregnancies.
Gu Y; Lewis DF; Wang Y
J Clin Endocrinol Metab; 2008 Jan; 93(1):260-6. PubMed ID: 17956952
[TBL] [Abstract][Full Text] [Related]
19. Placental gene expression patterns of endoglin (CD105) in intrauterine growth restriction.
Szentpéteri I; Rab A; Kornya L; Kovács P; Brubel R; Joó JG
J Matern Fetal Neonatal Med; 2014 Mar; 27(4):350-4. PubMed ID: 23808956
[TBL] [Abstract][Full Text] [Related]
20. Placental mitochondrial content and function in intrauterine growth restriction and preeclampsia.
Mandò C; De Palma C; Stampalija T; Anelli GM; Figus M; Novielli C; Parisi F; Clementi E; Ferrazzi E; Cetin I
Am J Physiol Endocrinol Metab; 2014 Feb; 306(4):E404-13. PubMed ID: 24347055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
